A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Clinical trial NCT06881836 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06881836
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-04-24
Primary completion: 2026-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.